Brookfield Wealth Solutions Ltd., through its subsidiaries, provides retirement services, wealth protection products, and capital solutions to individuals and institutions. It operates through Annuities, Property and Casualty (P&C), Life Insurance segments. The Annuities segment offers retail and institutional annuities, including fixed index, fixed rate, single premium immediate, and variable annuities, as well as pension risk transfer. The P&C segment provides property and specialty insurance products casualty insurance comprising specialty casualty, construction defect, general liability, commercial multi-peril, workers compensation, product and environmental liability, and auto liability. The Life Insurance segment offers whole life, universal life, and variable universal life insurance products. The company was formerly known as Brookfield Reinsurance Ltd. and changed its name to Brookfield Wealth Solutions Ltd. in September 2024. Brookfield Wealth Solutions Ltd. was incorporated in 2020 and is headquartered in Pembroke, Bermuda.

Brookfield Wealth Solutions Ltd.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Bioge...

Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)

In a report released yesterday, Chetan Udeshi from J.P. Morgan maintained a Sell rating on Brenntag AG. The company’s shares closed last Wednesday ...

J.P. Morgan Reaffirms Their Sell Rating on Brenntag AG (0MPT)

BioNTech SE ( ($BNTX) ) has issued an announcement. BioNTech SE said on September 18, 2026, that its Supervisory Board has approved the appointment...

BioNTech Names KPMG as New Independent Auditor for 2027 Financial Year

Bantas Bandirma Ambalaj Sanayi ve Ticaret A.S. ( ($TR:BNTAS) ) has shared an announcement. Trading in BNTAS shares on Borsa Istanbul was temporaril...

Borsa Istanbul Triggers Circuit Breaker in Bantas Bandirma Shares

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNTech SE (BNTX) and Vera Therapeutics (VERA) with...

Wall Street Analysts Are Bullish on Top Healthcare Picks

In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Buy rating on BioNTech SE, with a price target of $140.00. The compan...

Berenberg Bank Reaffirms Their Buy Rating on BioNTech SE (BNTX)

Jefferies analyst Akash Tewari maintained a Buy rating on BioNTech SE today and set a price target of $138.00. According to TipRanks, Tewari is a 5...

Jefferies Remains a Buy on BioNTech SE (BNTX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ocular Therapeutix (OCUL) and BioNTech SE (BNTX). ...

Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL) and BioNTech SE (BNTX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on High Tide (HITI), Cardiff Oncology (CRDF) and Benitec Biopharma (...

Analysts Conflicted on These Healthcare Names: High Tide (HITI), Cardiff Oncology (CRDF) and Benitec Biopharma (BNTC)

An update from BioNTech SE ( ($BNTX) ) is now available. BioNTech SE and U.S.-based OncoC4, Inc., both active in oncology immunotherapy, are jointl...

BioNTech and OncoC4 Report Survival Gains for Gotistobart in Phase 3 Squamous NSCLC Trial

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE, with a price target of $115.00. Flynn covers ...

BioNTech SE (BNTX) Gets a Buy from Morgan Stanley

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNT...

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arrowhead Pharmaceuticals (ARWR), BioNTech SE (BNTX)...

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), BioNTech SE (BNTX)

BioNTech SE ( ($BNTX) ) has fallen by -9.52%. Read on to learn why. BioNTech SE shares fell 9.52% over the past week, even as the company signaled ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BNT	$36.82	+0.63%	7.01K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BNT	$36.82	+0.6%	7.01K
3
4
5
6

BNT

Get Brookfield Wealth Solutions Ltd. Data in Excel

Get Brookfield Wealth Solutions Ltd. Data in Excel